← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Symphogen A/S
Lyngby
$4,537,764
Total funding
1
Grants
Funding over time
peak $2.1M · FY2006–08$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
Funding mix
By agency
NIH$4,537,764 · 1
By mechanism
U01$4,537,764 · 1
Investigators at Symphogen A/S
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Fully human recombinant therapeutic anti-vaccinia virus polyclonal antibody$2,074,124
U01 · FY2006 · AI
Fully human recombinant therapeutic anti-vaccinia virus polyclonal antibody$1,843,539
U01 · FY2007 · AI
Fully human recombinant therapeutic anti-vaccinia virus polyclonal antibody$620,101
U01 · FY2008 · AI